A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

COVID-19 At-Home Saliva Test Receives Emergency Authorization


The first at-home saliva test for COVID-19 received emergency authorization from the United States Food and Drug Administration on May 8. The test, produced by RUCDR Infinite Biologics out of Rutgers University in Piscataway, New Jersey, can now be sold for at-home use. With a cost of approximately $100, the tests must be prescribed by a healthcare provider and are recommended only for those who have COVID-19 symptoms. Patients need only to spit into a tube and then ship the secured tube back to the lab, with results ready within 48 hours. The current standard of care for testing is to have a healthcare provider swab deep into a patient’s nasal cavity, which is uncomfortable for some and painful to others. Experts hope the at-home test can broaden screening efforts for the novel coronavirus. Read more here.

For even more breaking news, follow us on Facebook.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy